New combo attack on HPV-Linked throat cancer
NCT ID NCT03799445
Summary
This study is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a targeted course of radiation is safe and effective for treating advanced throat cancer caused by HPV. The goal is to help the body's immune system better recognize and attack the cancer cells while using radiation to shrink tumors. It is for patients with a specific type and stage of HPV-positive throat cancer who have not had prior treatment for it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.